Touyun Biotech Group Limited
Touyun Biotech Group Limited (HKSE: 1332) is trading at HK$0.16, about ₹2 at today's HKD/INR rate, as of 24 Sep 2026, 9:34 PM ET. Indian residents can buy Touyun Biotech from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.16
Today's high
HK$0.16
52 week low
HK$0.07
52 week high
HK$0.75
1332 opened at HK$0.16, closed previously at HK$0.16, and has traded between HK$0.07 and HK$0.75 over the past 52 weeks.
About
Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.
Key statistics
Avg. volume
1.29M
Market cap
HK$443.28M
P/E Ratio
2.33
Price-to-sales ratio
6.26
Enterprise value
HK$921.01M
Free cash flow yield
-2.90%
Debt-to-equity ratio
3.41
Return on equity
473.76%
ROIC
-6.09%
Beta
-0.60
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
HK$66.97M
Earnings per share
HK$0.00
Free cash flow
-HK$32.60M
Net profit margin
301.26%
Gross margin
22.42%
EBITDA
-HK$47.87M
Revenue growth
-58.13%
Similar securities
This is not an investment recommendation
How to buy Touyun Biotech from India
Indian residents can buy Touyun Biotech shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Touyun Biotech and place an order
Find Touyun Biotech by name or by its ticker, 1332, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Touyun Biotech trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Touyun Biotech position in HKD and INR. Touyun Biotech pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Touyun Biotech from India
Trading and taxes when buying Touyun Biotech from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTouyun Biotech does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Touyun Biotech stock?
Yes. Touyun Biotech (1332) has been listed on the Hong Kong Stock Exchange since 2012, in the Packaging & Containers industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Touyun Biotech share cost in rupees?
One Touyun Biotech share is HK$0.16 — about ₹2 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Touyun Biotech price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Touyun Biotech from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Touyun Biotech?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Touyun Biotech shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Touyun Biotech price. Paasa issues a capital-gains statement for your return.
Does Touyun Biotech pay a dividend?
No. Touyun Biotech does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Touyun Biotech from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Touyun Biotech shares held from India?
Hong Kong has no estate duty.
Do I have to declare Touyun Biotech shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Touyun Biotech holding, its cost and its closing value.
How do I sell Touyun Biotech and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.